Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
33 Fruit St
Mass General Physican Organization
Boston, MA 02114Phone+1 617-724-7066Fax+1 617-726-5123
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Nuclear Medicine, 2001 - 2002
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1985 - 1986
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1982 - 1985
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 1981 - 1982
- University of Kansas School of MedicineClass of 1981
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 1988 - 2025
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- Detecting early cognitive deficits in preclinical Alzheimer's disease using a remote digital multi-day learning paradigm.Roos J Jutten, Daniel Soberanes, Cassidy P Molinare, Stephanie Hsieh, Michelle E Farrell
NPJ Digital Medicine. 2025-01-13 - Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.Gil D Rabinovici, David S Knopman, Javier Arbizu, Tammie L S Benzinger, Kevin J Donohoe
Journal of Nuclear Medicine. 2025-01-08 - Elevated locus coeruleus metabolism provides resilience against cognitive decline in preclinical Alzheimer's disease.Elouise A Koops, Joyita Dutta, Bernard J Hanseeuw, J Alex Becker, Maxime Van Egroo
Alzheimer's & Dementia. 2025-01-01
Journal Articles
- Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive ImpairmentJeffrey M Burns, Keith A Johnson, Reisa A Sperling, Jason Karlawish, JAMA Neurology
- Association of Factors with Elevated Amyloid Burden in Clinically Normal Older IndividualsReisa A Sperling, Eric Siemers, Keith A Johnson, JAMA Neurology
- Nonlinear Distributional Mapping (NoDiM) for Harmonization Across Amyloid-PET Radiotracers☆Jasmeer P Chhatwal, Reisa A Sperling, Keith A Johnson, ScienceDirect
- Join now to see all
Authored Content
- Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive ImpairmentAugust 2020
- Association of Factors with Elevated Amyloid Burden in Clinically Normal Older IndividualsApril 2020
- Sex, Amyloid, and APOE ε4 and Risk of Cognitive Decline in Preclinical Alzheimer's Disease: Findings from Three Well-Characterized CohortsMay 2018
Press Mentions
- Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
- AC Immune to Host Key Opinion Leader Event: 'Untangling' Tau Pathology to Treat Alzheimer's and Neurodegenerative DiseasesOctober 24th, 2019
- Physical Activity Moderates Amyloid-Beta Burden in Clinically Normal Older AdultsAugust 22nd, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: